{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:50:33Z","timestamp":1792713033992,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,6,16]],"date-time":"2016-06-16T00:00:00Z","timestamp":1466035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,6,16]],"date-time":"2016-06-16T00:00:00Z","timestamp":1466035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"German Federal Institute for Risk Assessment"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"published-print":{"date-parts":[[2016,8,1]]},"DOI":"10.15252\/emmm.201506025","type":"journal-article","created":{"date-parts":[[2016,6,16]],"date-time":"2016-06-16T21:18:52Z","timestamp":1466111932000},"page":"831-838","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Defining the optimal animal model for translational research using gene set enrichment analysis"],"prefix":"10.1038","volume":"8","author":[{"given":"Christopher","family":"Weidner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Steinfath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Opitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Oelgeschl\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6134-1990","authenticated-orcid":false,"given":"Gilbert","family":"Sch\u00f6nfelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,16]]},"reference":[{"key":"BFEMMM201506025_CR1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/491031a","volume":"491","author":"J Bolker","year":"2012","unstructured":"Bolker J (2012) Model organisms: there's more to life than rats and flies. Nature 491: 31\u201333","journal-title":"Nature"},{"key":"BFEMMM201506025_CR2","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/9783527682423.ch35","volume-title":"Handbook of Therapeutic Antibodies","author":"FR Brennan","year":"2014","unstructured":"Brennan FR (2014) Toll\u2010like receptor inhibitors in phase 1 and 2 clinical studies for immunological disorders. In Handbook of Therapeutic Antibodies, D\u00fcbel S, Reichert JM (eds), pp 1145\u20131158. Weinheim: Wiley\u2010VCH Verlag GmbH & Co. KGaA"},{"key":"BFEMMM201506025_CR3","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nrd1854","volume":"4","author":"JA Buras","year":"2005","unstructured":"Buras JA, Holzmann B, Sitkovsky M (2005) Animal models of sepsis: setting the stage. Nat Rev Drug Discov 4: 854\u2013865","journal-title":"Nat Rev Drug Discov"},{"key":"BFEMMM201506025_CR4","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1473-3099(15)70112-X","volume":"15","author":"J Cohen","year":"2015","unstructured":"Cohen J, Vincent JL, Adhikari NK, Machado FR, Angus DC, Calandra T, Jaton K, Giulieri S, Delaloye J, Opal S et\u00a0al (2015) Sepsis: a roadmap for future research. Lancet Infect Dis 15: 581\u2013614","journal-title":"Lancet Infect Dis"},{"key":"BFEMMM201506025_CR5","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrd3800","volume":"11","author":"CA Dinarello","year":"2012","unstructured":"Dinarello CA, Simon A, van der Meer JW (2012) Treating inflammation by blocking interleukin\u20101 in a broad spectrum of diseases. Nat Rev Drug Discov 11: 633\u2013652","journal-title":"Nat Rev Drug Discov"},{"key":"BFEMMM201506025_CR6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/cei.12645","volume":"181","author":"KH Egge","year":"2015","unstructured":"Egge KH, Barratt\u2010Due A, Nymo S, Lindstad JK, Pharo A, Lau C, Espevik T, Thorgersen EB, Mollnes TE (2015) The anti\u2010inflammatory effect of combined complement and CD14 inhibition is preserved during escalating bacterial load. Clin Exp Immunol 181: 457\u2013467","journal-title":"Clin Exp Immunol"},{"key":"BFEMMM201506025_CR7","first-page":"87","volume":"12","author":"European Food Safety Authority","year":"2014","unstructured":"European Food Safety Authority (2014) Modern methodologies and tools for human hazard assessment of chemicals. EFSA J 12: 87","journal-title":"EFSA J"},{"key":"BFEMMM201506025_CR8","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ki.2008.442","volume":"74","author":"MP Fink","year":"2008","unstructured":"Fink MP (2008) Animal models of sepsis and its complications. Kidney Int 74: 991\u2013993","journal-title":"Kidney Int"},{"key":"BFEMMM201506025_CR9","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nrd4368","volume":"13","author":"MP Fink","year":"2014","unstructured":"Fink MP, Warren HS (2014) Strategies to improve drug development for sepsis. Nat Rev Drug Discov 13: 741\u2013758","journal-title":"Nat Rev Drug Discov"},{"key":"BFEMMM201506025_CR10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrd3203","volume":"9","author":"EJ Hennessy","year":"2010","unstructured":"Hennessy EJ, Parker AE, O'Neill LA (2010) Targeting Toll\u2010like receptors: emerging therapeutics? Nat Rev Drug Discov 9: 293\u2013307","journal-title":"Nat Rev Drug Discov"},{"key":"BFEMMM201506025_CR11","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/nm0509-496","volume":"15","author":"RS Hotchkiss","year":"2009","unstructured":"Hotchkiss RS, Coopersmith CM, McDunn JE, Ferguson TA (2009) The sepsis\u00a0seesaw: tilting toward immunosuppression. Nat Med 15: 496\u2013497","journal-title":"Nat Med"},{"key":"BFEMMM201506025_CR12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1056\/NEJMcibr1004371","volume":"363","author":"RS Hotchkiss","year":"2010","unstructured":"Hotchkiss RS, Opal S (2010) Immunotherapy for sepsis\u2010a new approach against an ancient foe. N Engl J Med 363: 87\u201389","journal-title":"N Engl J Med"},{"key":"BFEMMM201506025_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkn923","volume":"37","author":"W da Huang","year":"2009","unstructured":"da Huang W, Sherman BT, Lempicki RA (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37: 1\u201313","journal-title":"Nucleic Acids Res"},{"key":"BFEMMM201506025_CR14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/ard.2008.105197","volume":"69","author":"G Jones","year":"2010","unstructured":"Jones G, Sebba A, Gu J, Lowenstein MB, Calvo A, Gomez\u2010Reino JJ, Siri DA, Tomsic M, Alecock E, Woodworth T et\u00a0al (2010) Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study. Ann Rheum Dis 69: 88\u201396","journal-title":"Ann Rheum Dis"},{"key":"BFEMMM201506025_CR15","unstructured":"National Research Council (US) (2007) Applications of Toxicogenomic Technologies to Predictive Toxicology and Risk Assessment. Committee on\u00a0Applications of Toxicogenomic Technologies to Predictive Toxicology and Risk Assessment (eds). Washington, DC: The National Academy Press."},{"key":"BFEMMM201506025_CR16","doi-asserted-by":"crossref","unstructured":"Pielaat A, Barker GC, Hendriksen P, Peijnenburg A, Kuile BH (2013) A foresight study on emerging technologies: State of the art of omics technologies and potential applications in food and feed safety. REPORT\u00a01: Review on the state of art of omics technologies in risk assessment related to food and feed safety. EFSA supporting publication EN\u2010495","DOI":"10.2903\/sp.efsa.2013.EN-495"},{"key":"BFEMMM201506025_CR17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3389\/fimmu.2013.00387","volume":"4","author":"A Savva","year":"2013","unstructured":"Savva A, Roger T (2013) Targeting toll\u2010like receptors: promising therapeutic strategies for the management of sepsis\u2010associated pathology and infectious diseases. Front Immunol 4: 387","journal-title":"Front Immunol"},{"key":"BFEMMM201506025_CR18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1515\/CCLM.1999.047","volume":"37","author":"RR Schumann","year":"1999","unstructured":"Schumann RR, Zweigner J (1999) A novel acute\u2010phase marker: lipopolysaccharide binding protein (LBP). Clin Chem Lab Med 37: 271\u2013274","journal-title":"Clin Chem Lab Med"},{"key":"BFEMMM201506025_CR19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/0300985811429314","volume":"49","author":"RS Sellers","year":"2012","unstructured":"Sellers RS, Clifford CB, Treuting PM, Brayton C (2012) Immunological variation between inbred laboratory mouse strains: points to consider in phenotyping genetically immunomodified mice. Vet Pathol 49: 32\u201343","journal-title":"Vet Pathol"},{"key":"BFEMMM201506025_CR20","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1073\/pnas.1222878110","volume":"110","author":"J Seok","year":"2013","unstructured":"Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, McDonald\u2010Smith GP, Gao H, Hennessy L et\u00a0al (2013) Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci USA 110: 3507\u20133512","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM201506025_CR21","doi-asserted-by":"crossref","first-page":"E346","DOI":"10.1073\/pnas.1416629111","volume":"112","author":"T Shay","year":"2015","unstructured":"Shay T, Lederer JA, Benoist C (2015) Genomic responses to inflammation in mouse models mimic humans: we concur, apples to oranges comparisons won't do. Proc Natl Acad Sci USA 112: E346","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM201506025_CR22","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1186\/s12864-015-2012-4","volume":"16","author":"L Spinelli","year":"2015","unstructured":"Spinelli L, Carpentier S, Montanana Sanchis F, Dalod M, Vu Manh TP (2015) BubbleGUM: automatic extraction of phenotype molecular signatures and comprehensive visualization of multiple Gene Set Enrichment Analyses. BMC Genom 16: 814","journal-title":"BMC Genom"},{"key":"BFEMMM201506025_CR23","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES et\u00a0al (2005) Gene set enrichment analysis: a knowledge\u2010based approach for interpreting genome\u2010wide expression profiles. Proc Natl Acad Sci USA 102: 15545\u201315550","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM201506025_CR24","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1073\/pnas.1401965111","volume":"112","author":"K Takao","year":"2015","unstructured":"Takao K, Miyakawa T (2015) Genomic responses in mouse models greatly mimic human inflammatory diseases. Proc Natl Acad Sci USA 112: 1167\u20131172","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM201506025_CR25","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.4049\/jimmunol.166.5.3599","volume":"166","author":"A Verbon","year":"2001","unstructured":"Verbon A, Dekkers PE, ten Hove T, Hack CE, Pribble JP, Turner T, Souza S, Axtelle T, Hoek FJ, van Deventer SJ et\u00a0al (2001) IC14, an anti\u2010CD14 antibody, inhibits endotoxin\u2010mediated symptoms and inflammatory responses in humans. J Immunol 166: 3599\u20133605","journal-title":"J Immunol"},{"key":"BFEMMM201506025_CR26","first-page":"E345","volume":"112","author":"HS Warren","year":"2015","unstructured":"Warren HS, Tompkins RG, Moldawer LL, Seok J, Xu W, Mindrinos MN, Maier RV, Xiao W, Davis RW (2015) Mice are not men. Proc Natl Acad Sci USA 112: E345","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 2","key":"BFEMMM201506025_CR27","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1755-8794-8-S2-S2","volume":"8","author":"L Yu","year":"2015","unstructured":"Yu L, Huang J, Ma Z, Zhang J, Zou Y, Gao L (2015) Inferring drug\u2010disease associations based on known protein complexes. BMC Med Genomics 8(Suppl 2): S2","journal-title":"BMC Med Genomics"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.201506025.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.15252\/emmm.201506025","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.15252\/emmm.201506025\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.15252\/emmm.201506025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.201506025.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:16:47Z","timestamp":1779085007000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.15252\/emmm.201506025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,16]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8,1]]}},"alternative-id":["BFEMMM201506025"],"URL":"https:\/\/doi.org\/10.15252\/emmm.201506025","relation":{},"ISSN":["1757-4676","1757-4684"],"issn-type":[{"value":"1757-4676","type":"print"},{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,16]]},"assertion":[{"value":"2 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declared that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}